{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:54:13Z","timestamp":1773687253689,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81202573"],"award-info":[{"award-number":["81202573"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81773745"],"award-info":[{"award-number":["81773745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.phymed.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T08:17:26Z","timestamp":1520324246000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3"],"prefix":"10.1016","volume":"42","author":[{"given":"Mengze","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2018.03.007_bib0001","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrrheum.2013.173-c1","article-title":"Gout treatment: when a tablet is not enough","volume":"10","author":"Alvarez-Lario","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amjmed.2016.06.040","article-title":"Update on importance of diet in gout","volume":"129","author":"Beyl","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phymed.2018.03.007_bib0003","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/clinchem\/17.3.158","article-title":"A simplified alkaline phosphotungstate assay for uric acid in serum","volume":"17","author":"Carroll","year":"1971","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phymed.2018.03.007_bib0005","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.12659\/MSM.899852","article-title":"Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview","volume":"22","author":"Chen","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.phymed.2018.03.007_bib0006","first-page":"330","article-title":"Anti-hyperuricemic and anti-inflammatory actions of vaticaffinol isolated from Dipterocarpus alatus in hyperuricemic mice","volume":"15","author":"Chen","year":"2017","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.phymed.2018.03.007_bib0007","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Gout. Lancet"},{"key":"10.1016\/j.phymed.2018.03.007_bib0008","first-page":"13747","article-title":"rs3806268 of NLRP3 gene polymorphism is associated with the development of primary gout","volume":"8","author":"Deng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mehy.2016.04.039","article-title":"Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation","volume":"92","author":"Demidowich","year":"2016","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.phymed.2018.03.007_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2016.06.005","article-title":"Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators","volume":"786","author":"Dhanasekar","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0011","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/BOR.0000000000000143","article-title":"Interleukin-1 as a therapeutic target in gout","volume":"27","author":"Dumusc","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0012","first-page":"125","article-title":"Use of newly available febuxostat in a case of chronic tophaceous gout contraindicated to allopurinol and probenecid","volume":"67","author":"Hilmi","year":"2012","journal-title":"Med. J. Malay."},{"key":"10.1016\/j.phymed.2018.03.007_bib0013","first-page":"2170","article-title":"Role of the leucine-rich repeat domain of cryopyrin\/NALP3 in monosodium urate crystal-induced inflammation in mice","volume":"62","author":"Hoffman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.phymed.2018.03.007_bib0014","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1189\/jlb.3A0114-005RR","article-title":"Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation","volume":"96","author":"Honda","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0015","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1021\/np400379u","article-title":"Cytotoxic deoxybenzoins and diphenylethylenes from Arundina graminifolia","volume":"76","author":"Hu","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2018.03.007_bib0016","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biopha.2016.12.002","article-title":"(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1","volume":"86","author":"Hu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2018.03.007_bib0017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.12688\/f1000research.9402.1","article-title":"Recent advances in understanding and managing gout","volume":"6","author":"Igel","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.phymed.2018.03.007_bib0018","first-page":"39","article-title":"The role of the NLRP3 inflammasome in gout","volume":"4","author":"Kingsbury","year":"2011","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.phymed.2018.03.007_bib0019","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201000107","article-title":"Design, synthesis, and immunosuppressive activity of new deoxybenzoin derivatives","volume":"5","author":"Li","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.phymed.2018.03.007_bib0020","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.bmcl.2010.01.032","article-title":"Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents","volume":"20","author":"Li","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2018.03.007_bib0021","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-017-0849-y","article-title":"Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression","volume":"14","author":"Liu","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phymed.2018.03.007_bib0022","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0023","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2018.03.007_bib0024","first-page":"WJ01","article-title":"Allopurinol induced stevens \u2013 johnson syndrome \u2013 a case report","volume":"9","author":"Paik","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.phymed.2018.03.007_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-017-0356-x","article-title":"Quercetin inhibits gout arthritis in mice: induction of an opioid-dependent regulation of inflammasome","author":"Ruiz-Miyazawa","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phymed.2018.03.007_bib0026","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-115-3-165","article-title":"Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease","volume":"115","author":"Sandler","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phymed.2018.03.007_bib0027","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1759720X16646703","article-title":"Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications","volume":"8","author":"Sattui","year":"2016","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.phymed.2018.03.007_bib0028","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jep.2017.03.043","article-title":"Protective effects of Cinnamomum cassia (Lamaceae) against gout and septic responses via attenuation of inflammasome activation in experimental models","volume":"205","author":"Shin","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2018.03.007_bib0029","first-page":"499","article-title":"Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice","volume":"14","author":"Wang","year":"2016","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.phymed.2018.03.007_bib0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2014-206074","article-title":"AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages","volume":"75","author":"Wang","year":"2016","journal-title":"Ann. Rheum. Dis."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318300382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318300382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:40:21Z","timestamp":1603932021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711318300382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"alternative-id":["S0944711318300382"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2018.03.007","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}